Mode
Text Size
Log in / Sign up
N/A N=135 Randomized Single-blind Treatment

Does Motivational Interviewing Improve Behavioral Weight Loss Outcomes for Obesity?

Obesity · Overweight

Enrolled (actual)
135
Serious AEs
Results posted
Mar 2017
Primary outcome: Primary: Weight at End of Behavioural Weight Loss Program, 12 Weeks — 89.02; 90.09 kilograms — p=>.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Motivational Interviewing (Behavioral); Attention Control (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Calgary
Primary completion
Jan 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Weight at End of Behavioural Weight Loss Program, 12 Weeks
89.02; 90.09 >.05
SECONDARY
Weight at 6 Month Follow up
91.26; 91.59 >.05
SECONDARY
Adherence
3.71; 4.07 .65
SECONDARY
BMI at End of Behavioural Weight Loss Program, Week 12
32.27; 32.64 >.05
SECONDARY
BMI at 6 Month Follow up
32.96; 33.11 >.05
SECONDARY
Physical Activity at End of the Behavioural Weight Loss Program, Week 12
2161.80; 2211.87 >.05
SECONDARY
Physical Activity at 1 Month Follow up
2196.78; 2299.22 >.05
SECONDARY
Physical Activity at 6 Month Follow up
2060.09; 1789.34 >.05
SECONDARY
Dietary Behaviour at End of the Behavioural Weight Loss Program, Week 12
2.64; 2.62 >.05
SECONDARY
Dietary Behaviour at 1 Month Follow up
2.71; 2.67 >.05
SECONDARY
Dietary Behaviour at 6 Month Follow up
2.80; 2.70 >.05
SECONDARY
Blood Pressure at End of the Behavioural Weight Loss Program, Week 12
127.84; 127.19; 77.48; 77.89 >.05
SECONDARY
Blood Pressure at 6 Month Follow up
128.93; 128.67; 76.77; 77.82 >.05
SECONDARY
Eating Disorder Symptomology at End of the Behavioural Weight Loss Program, Week 12
2.01; 2.07 >.05
SECONDARY
Eating Disorder Symptomology at 1 Month Follow up
1.91; 2.13 >.05
SECONDARY
Eating Disorder Symptomology at 6 Month Follow up
1.96; 1.92 >.05
SECONDARY
Self-efficacy Related to Eating Patterns After the First Motivational Interviewing or Attention Control Interview, Week 1 - 2
136.71; 130.71 >.05
SECONDARY
Self-efficacy for Engaging in Physical Activity After the First Motivational Interviewing or Attention Control Interview, Week 1- 2
3.28; 3.05 >.05
SECONDARY
Self-efficacy Related to Eating Patterns After the Second Motivational Interviewing or Attention Control Interview, Week 12
148.46; 147.44 >.05
SECONDARY
Self-efficacy for Engaging in Physical Activity After the Second Motivational Interviewing or Attention Control Interview, Week 12
3.58; 3.49 >.05
SECONDARY
Importance of Change Ratings After the First Motivational Interview or Attention Control Interview, Week 1 - 2
8.67; 8.73 >.05
SECONDARY
Readiness for Change Ratings After the First Motivational Interview or Attention Control Interview, Week 1 -2
8.64; 8.65 >.05
SECONDARY
Confidence for Change Ratings After the First Motivational Interview or Attention Control Interview, Week 1- 2
7.85; 8.06 >.05
SECONDARY
Importance for Change Ratings After the Second Motivational Interview or Attention Control Interview, Week 12
8.52; 8.88 >.05
SECONDARY
Readiness for Change Ratings After the Second Motivational Interviewing or Attention Control Interview, Week 12
8.70; 8.86 >.05
SECONDARY
Confidence for Change Ratings After the Second Motivational Interviewing or Attention Control Interview, Week 12
8.25; 8.39 >.05

Summary

The purpose of this study is to determine whether adding motivational interviewing (MI) to a behavioural weight loss program (BWLP) results in improved weight loss for adults who are overweight or obese.

Eligibility Criteria

Inclusion Criteria

  • Overweight to obese (BMI greater than or equal to 25 kilograms per meter squared).

Exclusion Criteria

  • Pregnancy (or intention of becoming pregnant within 9 months)
  • Health issues that would preclude participation in physical activity
  • Concurrent involvement in another weight loss program.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02649634). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search